News
Diagnostics-4-Future Conference 2024, Konstanz, Germany
On 16-17th of October 2024, MUGENBIO was attending the Diagnostics-4-Future Conference in Konstanz, Germany. We were represented there by our CEO, Dr Stanislaw Jozwiakowski.
https://www.diagnostics4future.org/
18th October 2024
10th Medical Innovation Event 2024, Biel, Switzerland
On 2nd of September 2024, our CEO, Dr Stanislaw Jozwiakowski had great pleasure to pitch our concept of the next generation platform for prostate cancer diagnostic to leading swiss medtech experts at the 10th Medical Innovation Event held in Biel Innovatin Park.
https://www.sipbb.ch/en/medtech-innovation-event-02-09-2024/
3rd September 2024
10th EU-Startups Summit 2024, Malta
On 9-10th of May 2024, MUGENBIO was attending the 10th EU-Startups Summit in Malta. We were represented there by our CEO, Dr Stanislaw Jozwiakowski.
https://www.eu-startups.com/eu-startups-summit-2024/
11th May 2024
Center for Urology, Hirslanden Clinic, Zurich, Switzerland
On 30th of April 2024, our CEO, Dr Stanislaw Jozwiakowski had priviledge to present our concept of the next generation platform for prostate cancer diagnostic to leading medical experts at the Center of Urology in Hirslanden Clinic, Zurich.
https://www.hirslanden.ch/en/klinik-hirslanden/centers/urology-centre.html
1st May 2024
Swiss Startup Association Founders Day 2024, Zurich, Switzerland
On 18th of April 2024, MUGENBIO was attending the Founders Day 2024, held at Google Campus in Zurich. We were represented there by our CEO, Dr Stanislaw Jozwiakowski.
https://swissstartupassociation.ch/past-events-highlights/
19th March 2024
Healthcare 2040: The Power of Foresight, Basel, Switzerland
On 12th of March 2024, MUGENBIO was attending the Healthcare 2040: The Power of Foresight, held at Novartis Campus, Basel. We were represented there by our CEO, Dr Stanislaw Jozwiakowski.
15th March 2024
MUGENBIO enters very important collaboration with crowda Sustainibility GmbH, Zurich, Switzerland
On 27th of January 2024, MUGENBIO signed collaboration agreement with crowda Sustainibility GmbH, Zurich Switzerland. The crowda will guide us in comprehensive development and correct implementation of sustainibility goals into MUGENBIO's business operations.
5th January 2024
MUGENBIO enters strategic collaboration with ZHAW, IMS, Winterthur, Switzerland
On 8th of December 2023, MUGENBIO signed collaboration agreement with ZHAW, IMS, Winterthur, Switzerland.
www.zhaw.ch/en/engineering/institutes-centres/ims
11th December 2023
Swiss Investors and Founders Meet up 2023, Zurich Switzerland
On 6th of December 2023, MUGENBIO was attending the Swiss Investors and Founders Meet up in Zurich. We were represented there by our CEO, Dr Stanislaw Jozwiakowski.
www.startupnetwork.eu/sne_events/the-swiss-founders-meetup-2023
7th December 2023
Startup Nights 2023, Winterthur, Switzerland
On 2nd and 3rd of Novmeber 2023, MUGENBIO was attending the biggest startup event organised in Switzerland. If you are interested in our vision, you can talk in person with our CEO, Dr Stanislaw Jozwiakowski.
4th November 2023
Open Innovation in Life Sciences Conference 2023, Zurich, Switzerland
On 26th and 27th of October 2023, MUGENBIO was attending the Open Innovation in Life Sciences Conference 2023, Zurich, Switzerland. We were represented there by our CEO, Dr Stanislaw Jozwiakowski.
28st October 2023
Innosuisse Grants Innovation Cheque to MUGENBIO
On 26th of October, 2023, Innosuisse granted Innovation Cheque to MUGENBIO, to support our proof of concept study validating our novel method for molecular analysis. The project will be carried out in collaboration with ZHAW, IMS, Winterthur, Switzerland.
27th October 2023